Profile Previews

Get a glimpse into our company and investor data—powered by the PitchBook Platform

Aequus Pharmaceuticals

Aequus Pharmaceuticals
2013 FOUNDED
PUBLIC STATUS
1-10 EMPLOYEES
AQS STOCK SYMBOL
2 INVESTMENTS
$0.15 SHARE PRICE (As of Tuesday Closing)
Description

Aequus Pharmaceuticals Inc is a Canada based specialty pharmaceutical company. It is focused on developing and commercializing differentiated products. The company manufactures and markets pharmaceutical drugs. Its sales and marketing activities are based in Canada, focusing on therapeutic areas including neurology, ophthalmology, and transplant. The products offered by the company include Topiramate XR, Oxcarbazepine XR, Tacrolimus Immediate Release, Vistitan, and other products. All of the company's operations are carried in Canada.

Ownership Status
Publicly Held
Financing Status
Corporate Backed or Acquired
Primary Industry
Drug Delivery
Other Industries
Pharmaceuticals
Stock Exchange
TSX
Primary Office
  • 2820-200 Granville Street
  • Vancouver, British Columbia V6C 1S4
  • Canada

+1 (604) 000-0000
Request full access to PitchBook

You’re viewing a free company profile from the PitchBook Platform. To explore Aequus Pharmaceuticals’s full profile, request a free trial.

Aequus Pharmaceuticals Stock Performance

52 wk Range Market Cap Prev. Close EPS Average Volume Shares
$0.10 - $0.31 $12.1M $0.15 -$0.03 165K 80.4M

Aequus Pharmaceuticals Financials Summary

In Thousands,
USD
TTM
30-Sep-2018
FY 2017
31-Dec-2017
FY 2016
31-Dec-2016
FY 2015
31-Dec-2015
Enterprise Value 11,682 15,046 9,260 17,385
Revenue 1,201 878 529 0
EBITDA (2,029) (2,856) (3,540) (3,863)
Net Income (2,162) (2,991) (3,630) (3,931)
Total Assets 2,155 2,125 1,495 1,751
Public Fundamental Data provided by Morningstar, Inc. disclaimer

Aequus Pharmaceuticals Valuation and Funding

Deal Type Date Amount Post-Val Valuation/
EBITDA
Debt Status

This information is reserved for PitchBook Platform users. To explore Aequus Pharmaceuticals‘s full profile, request access.

Request full access to PitchBook

Aequus Pharmaceuticals Investments & Acquisitions (2)

Company Name Deal Date Deal Type Deal Size Industry Lead Partner
00000000-00000 000 11-Jan-2018 00000 0000000 Biotechnology 0000000 000000
TeOra Health 28-Jul-2015 Merger/Acquisition 00.000 Other Commercial Services 0000000 000000
To view this company’s complete investment and acquisition history, request access »

Aequus Pharmaceuticals Executive Team (7)

Name Title Board
Seat
Contact
Info
Donald McAfee Ph.D Chief Scientific Officer
Ian Ball Chief Commercial Officer
Douglas Janzen Chief Executive Officer & Chairman
Ann Fehr Chief Financial Officer
Anne Stevens Chief Operating Officer & Director

2 Former Executives

You’re viewing 5 of 7 executives. Get the full list »

Aequus Pharmaceuticals Board Members (2)

Name Representing Role Since Contact
Info
0000000 000000 Self Chief Executive Officer & Chairman 000 0000

1 Former Board Member

You’re viewing 1 of 2 board members. Get the full list »